Hipgnosis Songs Fund Limited

Notice of Dividend Amount • Sep 21, 2023

National Storage Mechanism | Additional information

RNS Number : 1303N

Hipgnosis Songs Fund Limited

21 September 2023

LEI: 213800XJIPNDVKXMOC11

21 September 2023

HIPGNOSIS SONGS FUND LIMITED

(the "Company" or "Hipgnosis")

Interim Dividend Announcement

The Board of Hipgnosis, the first UK listed investment company offering investors a pure-play exposure to songs and associated musical intellectual property rights, and its Investment Adviser, Hipgnosis Song Management Limited, are pleased to announce the Company's interim dividend (the 'Dividend') for the period from 1 April to 30 June 2023 in respect of the Ordinary Shares.

The Dividend of 1.3125 pence per Ordinary Share will be payable to Shareholders on the register as at 29 September 2023 with an associated ex-dividend date of 28 September 2023 and a payment date of 27 October 2023.

For further information please contact: Hipgnosis Song Management Merck Mercuriadis Chris Helm Giles Croot (Media) Rufina Pavry (Investors)	+44 (0)20 4542 1511 +44 (0)20 4542 1530
Singer Capital Markets - Joint Corporate Broker James Moat / James Maxwell / Alex Emslie (Corporate Finance) Alan Geeves / James Waterlow / Sam Greatrex (Sales)	+44 (0)20 7496 3000
J.P. Morgan Cazenove - Joint Corporate Broker William Simmonds / Jérémie Birnbaum (Corporate Finance) James Bouverat (Sales)	+44 (0)20 7742 4000
RBC Capital Markets - Joint Corporate Broker Elliot Thomas / Max Avison (Corporate Finance) Lisa Tugwell / Anastasia Mikhailova (Sales)	+44 (0)20 7635 4000
Ocorian - Company Secretary & Administrator Lorna Zimny	+44 (0) 28 9693 0222
The Outside Organisation Alan Edwards / Nick Caley	+44 (0)7711 081 843
All US music publicity enquiries Fran Defeo	+1 917 767 5255

NOTES TO EDITORS

About Hipgnosis Songs Fund Limited

(www.hipgnosissongs.com)

Hipgnosis Songs Fund, which was founded by Merck Mercuriadis, is a Guernsey registered investment company established to offer investors a pure-play exposure to songs and associated musical intellectual property rights.  In March 2020 became a constituent of the FTSE 250 Index. Since April 2021, the Company has been resident in the UK for tax purposes and is recognised as an investment trust under applicable HMRC regulations.

About Hipgnosis Song Management Limited

The Company's Investment Adviser is Hipgnosis Song Management Limited, which was founded by Merck Mercuriadis, former manager of globally successful recording artists, such as Elton John, Guns N' Roses, Morrissey, Iron Maiden and Beyoncé, and hit songwriters such as Diane Warren, Justin Tranter and The-Dream, and former CEO of The Sanctuary Group plc. The Investment Adviser has assembled an Advisory Board of highly successful music industry experts which include award winning members of the artist, songwriter, publishing, legal, financial, recorded music and music management communities, all with in-depth knowledge of music publishing. Members of Hipgnosis Song Management Limited Advisory Board include Nile Rodgers, The-Dream, Giorgio Tuinfort, Starrah, David A. Stewart, Poo Bear, Bill Leibowitz, Ian Montone and Rodney Jerkins.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DIVLMMRTMTITBFJ